As immune-mediated inflammatory diseases converge across specialties, the connection between dermatology and gastrointestinal research has never been more apparent—and more important. This article explores how shared cytokine pathways, biologic therapies, and operational strategies allow dermatology expertise to translate seamlessly into GI trials. Read it now to discover how Symbio bridges therapeutics to accelerate timelines and strengthen data quality in inflammatory studies.